Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?
entrepreneur.com
business
2022-10-19 05:21:00

Shares of Johnson & Johnson (NYSE:JNJ) are down slightly despite the company scoring a double beat for its third quarter earnings. J&J reported earnings per share (EPS) of $2.55 on revenue of $23.79 billion. This was better than the analysts' forecast for EPS of $2.49 on revenue of $23.43 billion. However, the EPS number was 1.9% lower than in the same quarter the prior year.
But the stock is down about 0.5% in late-day trading due to the company's guidance. For the full year 2022, the company is also lowering (i.
